| Clinical data | |
|---|---|
| Trade names | Stenobolone, Anatrofin |
| Other names | RS-2106; S-3760; 2-Methyl-4,5α-dihydro-δ1-testosterone 17β-acetate; 2-Methyl-δ1-DHT 17β-acetate; 2-Methyl-5α-androst-1-en-17β-ol-3-one 17β-acetate |
| Routes of administration | Intramuscular injection |
| Drug class | Androgen;Anabolic steroid;Androgen ester |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C22H32O3 |
| Molar mass | 344.495 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Stenbolone acetate (USANTooltip United States Adopted Name) (brand nameStenobolone,Anatrofin; former developmental code namesRS-2106,S-3760), also known as2-methyl-4,5α-dihydro-δ1-testosterone 17β-acetate (2-methyl-δ1-DHT 17β-acetate) or as2-methyl-5α-androst-1-en-17β-ol-3-one 17β-acetate, is asynthetic,injectedanabolic–androgenic steroid (AAS) andderivative ofdihydrotestosterone (DHT) which has been marketed inSpain.[1][2][3]
It is the C17βacetateester ofstenbolone, which is structurally related to1-testosterone (Δ1-DHT; dihydroboldenone) and todrostanolone (2α-methyl-DHT).[1][2][3]
Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |